GV

Gaurav Vishnudas Lunge

Active Director Director DIN 10166099
DIN 10166099 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Gaurav Vishnudas Lunge

Data last updated:

Gaurav Vishnudas Lunge is a Director at Midline Path Lab Private Limited (since 2023). Midline Path Lab Private Limited reported revenue of ₹3 Lakh (FY 2025).

DIN 10166099
Primary Designation Director
First Appointment 17 May 2023
Oldest Company Age 3 yrs
Largest company Midline Path Lab Private Limited · ₹3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Midline Path Lab Private Limited U47721MH2023PTC403083
Director17 May 20232023₹3 Lakh (FY 2025)Active

Board colleagues of Gaurav Vishnudas Lunge

Directorship timeline

Open interactive timeline →
Midline Path Lab Private Limited
Premium access

Shareholding and investment profile for Gaurav Vishnudas Lunge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Vishnudas Lunge

Gaurav Vishnudas Lunge currently holds 1 directorship: Midline Path Lab Private Limited (Director, since 17 May 2023, revenue ₹3 Lakh (FY 2025)).

Gaurav Vishnudas Lunge was first appointed on 17 May 2023 as Director at Midline Path Lab Private Limited.

The current boards of Gaurav Vishnudas Lunge's companies include Amol Bhagwatrao Thakare (Midline Path Lab Private Limited), Sonal Abhilesh Dhawade (Midline Path Lab Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available